Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine. . . . → Read More: Trial Requested for Covid-19 Vaccine Nasal Spray
|
|||||
|
       
  |
A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches 
Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments 
Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs. . . . → Read More: Blood Cells Transport Enzymes to Slow Cancer Spread  Comments are closed  New products  biomedical, biotechnology, cancer, chemistry, engineering, life sciences, materials science, nanotechnology, patent, pharmaceuticals, preclinical, university 
An engineering lab developed a chip device that uses gene editing and an electric field to detect viruses responsible for Covid-19 infections. . . . → Read More: Electric Crispr Chip Quickly Detects Covid-19 Virus One comment - (Comments are closed) New products biomedical, chemistry, Covid-19, engineering, entrepreneurs, genomics, life sciences, medical device, physical sciences, preclinical, university 
Two biotechnology companies are developing synthetic antibodies to treat Covid-19 infections formulated as an inhaled dry powder rather than an infusion. . . . → Read More: Inhaled Dry-Powder Covid-19 Antibodies in the Works One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, life sciences, patent, pharmaceuticals, physical sciences, preclinical, university 
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components. . . . → Read More: Novartis Gains Synthetic Protein Therapies for Covid-19 2 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, Covid-19, equity, Europe, investment, licensing, life sciences, pharmaceuticals, preclinical 
A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment. . . . → Read More: Carb-X Funding Nanoscale Sponge to Treat Sepsis Comments are closed Finance, New products biomedical, biotechnology, engineering, entrepreneurs, grant, life sciences, manufacturing, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells. . . . → Read More: Cancer Center, Biotech Partner on Off-the-Shelf T-Cells One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, cancer, clinical trials, entrepreneurs, genomics, life sciences, pharmaceuticals, preclinical, university 
A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston. . . . → Read More: Start-Up Gains Access to Vaccine Nasal Spray Technology Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, engineering, entrepreneurs, licensing, life sciences, pharmaceuticals, physical sciences, preclinical, university |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||